CIK 0001095981 · Non-accelerated filer<br>Smaller reporting company
CERENOME, INC.
Sign in to watch- Ticker
- CNSY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330827593
- Phone
- 737.255.7194
- Business address
- 6420 LEVIT GREEN BOULEVARD, SUITE 310, HOUSTON, TX, 77021
- Former names
- PLUS THERAPEUTICS, INC., CYTORI THERAPEUTICS, INC., MACROPORE INC
- 4 Option exercise Chief Executive Officer acquired 62,500 shares (option exercise)
- 4 Option exercise Director acquired 7,676 shares (option exercise)
- 4 Open-market buy Director bought 5,000 shares at $4.90 ($24,500)
- 4 Open-market buy Director bought 5,000 shares at $4.74 ($23,700)
- 4 Open-market buy Director bought 20,000 shares at an average $4.25 ($84,900)
- 4 Open-market buy Director bought 5,000 shares at $3.98 ($19,900)
- 4 Open-market buy Director bought 10,000 shares at $3.50 ($35,000)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Executive or director change
- SC 13G Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- DEFA14A Proxy Proxy Materials
- D Other Notice of Sales of Unregistered Securities
- ARS Other Annual Report to Security Holders
- EFFECT Other Notice of Effectiveness
- 424B5 Offering Prospectus
- 8-K Event Material agreement
- S-3 Offering Registration Statement
Page 54 of 74 · 1,465 filings